Hyperkalemia Treatment Market

Hyperkalemia is a diseases in which levels of potassium are higher than normal level (3.5 and 5.0 mmol/L) in blood serum. Kidneys are responsible for managing potassium balance in the body by regulating its excretion as well as its intake. A person is prone to develop hyperkalemia when the consumption of potassium exceeds that of kidneys? potential to excrete it. The right amount of potassium and sodium in the body play a vital role in normal functioning of the myocardium.

Hyperkalemia can occur due to congestive heart failure, chronic kidney disease, or diabetic kidney disease. The condition can also occur when a patient receives renin-angiotensin-aldosterone system inhibitors (RAAS) in kidney disease. Abnormal levels of potassium can lead to irregular heartbeats, which can be fatal. Hyperkalemia is diagnosed by kidney functioning test, creatinine blood test, blood tests, and glucose monitoring.
Hyperkalemia Treatment Market aims to provide a comprehensive presentation of the global market for Hyperkalemia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperkalemia Treatment. Hyperkalemia Treatment Market contains market size and forecasts of Hyperkalemia Treatment in global, including the following market information:
Global Hyperkalemia Treatment Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Hyperkalemia Treatment Market Sales, 2018-2023, 2024-2030, (K Dose)
Global top five Hyperkalemia Treatment companies in 2022 (%)
The global Hyperkalemia Treatment market was valued at US$ 555.6 million in 2022 and is projected to reach US$ 700.7 million by 2030, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The main manufacturers of Global Hyperkalemia Treatment include Vifor Pharma, Astrazeneca, etc. These top two manufacturers hold a market share about 50%. North America and Europe are the major producing regions in the world.
We surveyed the Hyperkalemia Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hyperkalemia Treatment Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Hyperkalemia Treatment Market Segment Percentages, by Type, 2022 (%)
Sodium Bicarbonate
Beta2 Agonists
Diuretics
Others
Global Hyperkalemia Treatment Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Hyperkalemia Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Clinic
Other
Global Hyperkalemia Treatment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Hyperkalemia Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hyperkalemia Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hyperkalemia Treatment revenues share in global market, 2022 (%)
Key companies Hyperkalemia Treatment sales in global market, 2018-2023 (Estimated), (K Dose)
Key companies Hyperkalemia Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ardelyx
Astrazeneca Plc
Vifor Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hyperkalemia Treatment, market overview.
Chapter 2: Global Hyperkalemia Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Hyperkalemia Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hyperkalemia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hyperkalemia Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.